Pipeline Embolization Device in Aneurysmal Subarachnoid Hemorrhage

被引:71
作者
Cruz, J. P. [1 ]
O'Kelly, C. [3 ]
Kelly, M. [4 ]
Wong, J. H. [5 ]
Alshaya, W. [3 ]
Martin, A. [2 ]
Spears, J. [1 ,2 ]
Marotta, T. R. [1 ]
机构
[1] Univ Toronto, St Michaels Hosp, Div Neuroradiol, Dept Med Imaging, Toronto, ON, Canada
[2] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada
[3] Univ Edmonton, Dept Surg, Div Neurosurg, Edmonton, AB, Canada
[4] Univ Saskatchewan, Div Neurosurg, Dept Surg, Saskatoon, SK, Canada
[5] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada
关键词
INTERNAL CAROTID-ARTERY; RUPTURED INTRACRANIAL ANEURYSMS; FLOW-DISRUPTING DEVICE; BLISTER-LIKE ANEURYSMS; ENDOVASCULAR TREATMENT; PART I; STENT; DIVERSION; DISSECTION; THROMBOSIS;
D O I
10.3174/ajnr.A3380
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The PED is an FDS designed for the treatment of intracranial aneurysms. Data regarding the use of this device in acute or subacute aSAH is limited to a few case reports or small series. We aimed to demonstrate the feasibility of using an FDS, the PED, for the treatment of ruptured intracranial aneurysms with challenging morphologies. MATERIALS AND METHODS: We conducted a retrospective review of all known patients treated with the PED for aSAH at 4 institutions between June 2008 and January 2012. Pertinent clinical and radiologic information was submitted by individual centers for central collation. The decision to treat with the PED was made on a case-by-case basis by a multidisciplinary team under compassionate use. RESULTS: Twenty patients (15 women; median age, 54.5 years; IQR, 8.0 years) were found. There were 8 blister, 8 dissecting or dysplastic, 2 saccular, and 2 giant aneurysms. Median time to treatment was 4 days (range, 1-90 days; IQR, 12.75 days) from rupture. Three patients had previous failed treatment. Procedure-related symptomatic morbidity and mortality were 15%, with 1 (5%) procedure-related death. Two patients died relative to medical complications, and 1 patient was lost to follow-up. Sixteen patients were available for follow-up, 81% had a GOS of 5, and 13% had a GOS of 4 attributed to a poorer initial clinical presentation. One patient died of urosepsis at 4 months. Occlusion rates were 75% and 94% at 6 months and 12 months, respectively. There were 3 delayed complications (1 silent perforator infarct, 2 moderate asymptomatic in-stent stenoses). No symptomatic delayed complications or rehemorrhages occurred. CONCLUSIONS: The FDS may be a feasible treatment option in the acute or subacute setting of selected ruptured aneurysms, especially blister aneurysms. Ruptured giant aneurysms remain challenging for both surgical and endovascular techniques; at this stage, FDSs should be used with caution in this aneurysm subtype.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 53 条
[21]   Mural destabilization after aneurysm treatment with a flow-diverting device: a report of two cases [J].
Hampton, Timothy ;
Walsh, Donal ;
Tolias, Christos ;
Fiorella, David .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2011, 3 (02) :167-171
[22]   Pathological consideration of a ''blister-like'' aneurysm at the superior wall of the internal carotid artery: Case report [J].
Ishikawa, T ;
Nakamura, N ;
Houkin, K ;
Nomura, M .
NEUROSURGERY, 1997, 40 (02) :403-405
[23]   A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms [J].
Kallmes, D. F. ;
Ding, Y. H. ;
Dai, D. ;
Kadirvel, R. ;
Lewis, D. A. ;
Cloft, H. J. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (06) :1153-1158
[24]   A new endoluminal, flow-disrupting device for treatment of saccular aneurysms [J].
Kallmes, David F. ;
Ding, Yong Hong ;
Dai, Daying ;
Kadirvel, Ramanathan ;
Lewis, Debra A. ;
Cloft, Harry J. .
STROKE, 2007, 38 (08) :2346-2352
[25]   Ruptured giant intracranial aneurysms. Part I. A study of rebleeding [J].
Khurana, VG ;
Piepgras, DG ;
Whisnant, JP .
JOURNAL OF NEUROSURGERY, 1998, 88 (03) :425-429
[26]   Very Late Thrombosis of Flow-Diverting Constructs after the Treatment of Large Fusiform Posterior Circulation Aneurysms [J].
Klisch, J. ;
Turk, A. ;
Turner, R. ;
Woo, H. H. ;
Fiorella, D. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (04) :627-632
[27]   Intracranial aneurysms: from vessel wall pathology to therapeutic approach [J].
Krings, Timo ;
Mandell, Daniel M. ;
Kiehl, Tim-Rasmus ;
Geibprasert, Sasikhan ;
Tymianski, Michael ;
Alvarez, Hortensia ;
terBrugge, Karel G. ;
Hans, Franz-Josef .
NATURE REVIEWS NEUROLOGY, 2011, 7 (10) :547-559
[28]   Intra-Aneurysmal Thrombosis as a Possible Cause of Delayed Aneurysm Rupture after Flow-Diversion Treatment [J].
Kulcsar, Z. ;
Houdart, E. ;
Bonafe, A. ;
Parker, G. ;
Millar, J. ;
Goddard, A. J. P. ;
Renowden, S. ;
Gal, G. ;
Turowski, B. ;
Mitchell, K. ;
Gray, F. ;
Rodriguez, M. ;
van den Berg, R. ;
Gruber, A. ;
Desal, H. ;
Wanke, I. ;
Ruefenacht, D. A. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (01) :20-25
[29]   Effect of Flow Diversion Treatment on Very Small Ruptured Aneurysms [J].
Kulcsar, Zsolt ;
Wetzel, Stephan G. ;
Augsburger, Luca ;
Gruber, Andreas ;
Wanke, Isabel ;
Ruefenacht, Daniel Andre .
NEUROSURGERY, 2010, 67 (03) :789-793
[30]   High-Profile Flow Diverter (Silk) Implantation in the Basilar Artery Efficacy in the Treatment of Aneurysms and the Role of the Perforators [J].
Kulcsar, Zsolt ;
Ernemann, Ulrike ;
Wetzel, Stephan G. ;
Bock, Alexander ;
Goericke, Sophia ;
Panagiotopoulos, Vasilis ;
Forsting, Michael ;
Ruefenacht, Daniel A. ;
Wanke, Isabel .
STROKE, 2010, 41 (08) :1690-1696